nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—CYP3A7—Estradiol—osteoporosis	0.0811	0.151	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0811	0.151	CbGbCtD
Oxazepam—CYP3A5—Estradiol—osteoporosis	0.0608	0.113	CbGbCtD
Oxazepam—CYP3A4—Estropipate—osteoporosis	0.0571	0.106	CbGbCtD
Oxazepam—CYP3A4—Calcitriol—osteoporosis	0.0571	0.106	CbGbCtD
Oxazepam—CYP3A4—Ergocalciferol—osteoporosis	0.0457	0.0849	CbGbCtD
Oxazepam—CYP3A4—Raloxifene—osteoporosis	0.0381	0.0708	CbGbCtD
Oxazepam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0368	0.0684	CbGbCtD
Oxazepam—CYP3A4—Cholecalciferol—osteoporosis	0.0294	0.0547	CbGbCtD
Oxazepam—CYP3A4—Conjugated Estrogens—osteoporosis	0.027	0.0502	CbGbCtD
Oxazepam—CYP3A4—Estradiol—osteoporosis	0.0237	0.0441	CbGbCtD
Oxazepam—Stupor—Calcium Acetate—osteoporosis	0.0146	0.0367	CcSEcCtD
Oxazepam—Depressed level of consciousness—Calcium Acetate—osteoporosis	0.0105	0.0264	CcSEcCtD
Oxazepam—Drug eruption—Ibandronate—osteoporosis	0.00963	0.0242	CcSEcCtD
Oxazepam—Incontinence—Estradiol—osteoporosis	0.00935	0.0235	CcSEcCtD
Oxazepam—Slurred speech—Estradiol—osteoporosis	0.00731	0.0184	CcSEcCtD
Oxazepam—Blood disorder—Ibandronate—osteoporosis	0.00709	0.0178	CcSEcCtD
Oxazepam—Menstruation irregular—Estradiol—osteoporosis	0.0059	0.0148	CcSEcCtD
Oxazepam—Amnesia—Etidronic acid—osteoporosis	0.00552	0.0139	CcSEcCtD
Oxazepam—Hepatic function abnormal—Estropipate—osteoporosis	0.00513	0.0129	CcSEcCtD
Oxazepam—Amnesia—Ibandronate—osteoporosis	0.00458	0.0115	CcSEcCtD
Oxazepam—Syncope—Calcium Acetate—osteoporosis	0.00426	0.0107	CcSEcCtD
Oxazepam—Loss of consciousness—Calcium Acetate—osteoporosis	0.00418	0.0105	CcSEcCtD
Oxazepam—Oedema—Calcium Acetate—osteoporosis	0.00388	0.00977	CcSEcCtD
Oxazepam—Hepatic function abnormal—Pamidronate—osteoporosis	0.00385	0.0097	CcSEcCtD
Oxazepam—Shock—Calcium Acetate—osteoporosis	0.00382	0.00961	CcSEcCtD
Oxazepam—Agranulocytosis—Etidronic acid—osteoporosis	0.00373	0.00938	CcSEcCtD
Oxazepam—Hypotension—Calcium Acetate—osteoporosis	0.00363	0.00913	CcSEcCtD
Oxazepam—Hallucination—Etidronic acid—osteoporosis	0.00357	0.00898	CcSEcCtD
Oxazepam—Paraesthesia—Calcium Acetate—osteoporosis	0.00348	0.00877	CcSEcCtD
Oxazepam—Dysarthria—Estradiol—osteoporosis	0.00345	0.00869	CcSEcCtD
Oxazepam—Lethargy—Pamidronate—osteoporosis	0.00344	0.00865	CcSEcCtD
Oxazepam—Hepatic function abnormal—Conjugated Estrogens—osteoporosis	0.00339	0.00853	CcSEcCtD
Oxazepam—Disorientation—Conjugated Estrogens—osteoporosis	0.00331	0.00834	CcSEcCtD
Oxazepam—Drowsiness—Calcitriol—osteoporosis	0.00324	0.00816	CcSEcCtD
Oxazepam—Lethargy—Zoledronate—osteoporosis	0.00314	0.0079	CcSEcCtD
Oxazepam—Hypersensitivity—Calcium Acetate—osteoporosis	0.00286	0.0072	CcSEcCtD
Oxazepam—Leukopenia—Etidronic acid—osteoporosis	0.00279	0.00703	CcSEcCtD
Oxazepam—Hepatic function abnormal—Estradiol—osteoporosis	0.00271	0.00683	CcSEcCtD
Oxazepam—Dizziness—Calcium Acetate—osteoporosis	0.00257	0.00646	CcSEcCtD
Oxazepam—Amnesia—Estradiol—osteoporosis	0.00252	0.00635	CcSEcCtD
Oxazepam—Vertigo—Estropipate—osteoporosis	0.00243	0.00611	CcSEcCtD
Oxazepam—Agranulocytosis—Pamidronate—osteoporosis	0.00242	0.0061	CcSEcCtD
Oxazepam—Lethargy—Estradiol—osteoporosis	0.00242	0.00609	CcSEcCtD
Oxazepam—Vertigo—Alendronate—osteoporosis	0.00239	0.00601	CcSEcCtD
Oxazepam—Vertigo—Raloxifene—osteoporosis	0.00235	0.00591	CcSEcCtD
Oxazepam—Syncope—Raloxifene—osteoporosis	0.00235	0.0059	CcSEcCtD
Oxazepam—Agitation—Calcitriol—osteoporosis	0.00233	0.00586	CcSEcCtD
Oxazepam—Vertigo—Ibandronate—osteoporosis	0.00233	0.00586	CcSEcCtD
Oxazepam—Nausea—Calcium Acetate—osteoporosis	0.0023	0.0058	CcSEcCtD
Oxazepam—Loss of consciousness—Raloxifene—osteoporosis	0.0023	0.00579	CcSEcCtD
Oxazepam—Paraesthesia—Etidronic acid—osteoporosis	0.00229	0.00576	CcSEcCtD
Oxazepam—Agranulocytosis—Zoledronate—osteoporosis	0.00221	0.00557	CcSEcCtD
Oxazepam—Oedema—Estropipate—osteoporosis	0.0022	0.00555	CcSEcCtD
Oxazepam—Shock—Raloxifene—osteoporosis	0.0021	0.00529	CcSEcCtD
Oxazepam—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00208	0.00524	CcSEcCtD
Oxazepam—Shock—Ibandronate—osteoporosis	0.00208	0.00523	CcSEcCtD
Oxazepam—Nausea—Ergocalciferol—osteoporosis	0.00204	0.00512	CcSEcCtD
Oxazepam—Abdominal pain—Etidronic acid—osteoporosis	0.00201	0.00507	CcSEcCtD
Oxazepam—Paraesthesia—Estropipate—osteoporosis	0.00198	0.00498	CcSEcCtD
Oxazepam—Somnolence—Estropipate—osteoporosis	0.00196	0.00493	CcSEcCtD
Oxazepam—Vertigo—Risedronate—osteoporosis	0.00192	0.00483	CcSEcCtD
Oxazepam—Syncope—Risedronate—osteoporosis	0.00191	0.00482	CcSEcCtD
Oxazepam—Paraesthesia—Ibandronate—osteoporosis	0.0019	0.00478	CcSEcCtD
Oxazepam—Hypersensitivity—Etidronic acid—osteoporosis	0.00188	0.00472	CcSEcCtD
Oxazepam—Loss of consciousness—Risedronate—osteoporosis	0.00188	0.00472	CcSEcCtD
Oxazepam—Agitation—Pamidronate—osteoporosis	0.00186	0.00469	CcSEcCtD
Oxazepam—Somnolence—Calcitriol—osteoporosis	0.00184	0.00463	CcSEcCtD
Oxazepam—Syncope—Pamidronate—osteoporosis	0.00182	0.00458	CcSEcCtD
Oxazepam—Leukopenia—Pamidronate—osteoporosis	0.00182	0.00457	CcSEcCtD
Oxazepam—Gastrointestinal pain—Estropipate—osteoporosis	0.0018	0.00454	CcSEcCtD
Oxazepam—Oedema—Ethinyl Estradiol—osteoporosis	0.00179	0.0045	CcSEcCtD
Oxazepam—Loss of consciousness—Pamidronate—osteoporosis	0.00178	0.00449	CcSEcCtD
Oxazepam—Jaundice—Estradiol—osteoporosis	0.00178	0.00448	CcSEcCtD
Oxazepam—Gastrointestinal pain—Alendronate—osteoporosis	0.00178	0.00447	CcSEcCtD
Oxazepam—Vision blurred—Zoledronate—osteoporosis	0.00175	0.0044	CcSEcCtD
Oxazepam—Gastrointestinal pain—Raloxifene—osteoporosis	0.00175	0.00439	CcSEcCtD
Oxazepam—Abdominal pain—Estropipate—osteoporosis	0.00174	0.00438	CcSEcCtD
Oxazepam—Body temperature increased—Estropipate—osteoporosis	0.00174	0.00438	CcSEcCtD
Oxazepam—Tremor—Zoledronate—osteoporosis	0.00174	0.00437	CcSEcCtD
Oxazepam—Gastrointestinal pain—Ibandronate—osteoporosis	0.00173	0.00435	CcSEcCtD
Oxazepam—Abdominal pain—Alendronate—osteoporosis	0.00172	0.00432	CcSEcCtD
Oxazepam—Body temperature increased—Alendronate—osteoporosis	0.00172	0.00432	CcSEcCtD
Oxazepam—Shock—Risedronate—osteoporosis	0.00171	0.00431	CcSEcCtD
Oxazepam—Agitation—Zoledronate—osteoporosis	0.0017	0.00429	CcSEcCtD
Oxazepam—Gastrointestinal pain—Calcitriol—osteoporosis	0.00169	0.00426	CcSEcCtD
Oxazepam—Abdominal pain—Raloxifene—osteoporosis	0.00169	0.00425	CcSEcCtD
Oxazepam—Body temperature increased—Raloxifene—osteoporosis	0.00169	0.00425	CcSEcCtD
Oxazepam—Vision blurred—Conjugated Estrogens—osteoporosis	0.00168	0.00423	CcSEcCtD
Oxazepam—Abdominal pain—Ibandronate—osteoporosis	0.00167	0.0042	CcSEcCtD
Oxazepam—Body temperature increased—Ibandronate—osteoporosis	0.00167	0.0042	CcSEcCtD
Oxazepam—Vertigo—Zoledronate—osteoporosis	0.00166	0.00419	CcSEcCtD
Oxazepam—Syncope—Zoledronate—osteoporosis	0.00166	0.00418	CcSEcCtD
Oxazepam—Leukopenia—Zoledronate—osteoporosis	0.00166	0.00417	CcSEcCtD
Oxazepam—Oedema—Pamidronate—osteoporosis	0.00166	0.00417	CcSEcCtD
Oxazepam—Abdominal pain—Calcitriol—osteoporosis	0.00164	0.00412	CcSEcCtD
Oxazepam—Body temperature increased—Calcitriol—osteoporosis	0.00164	0.00412	CcSEcCtD
Oxazepam—Shock—Pamidronate—osteoporosis	0.00163	0.0041	CcSEcCtD
Oxazepam—Loss of consciousness—Zoledronate—osteoporosis	0.00163	0.0041	CcSEcCtD
Oxazepam—Hypersensitivity—Estropipate—osteoporosis	0.00162	0.00409	CcSEcCtD
Oxazepam—Rash—Etidronic acid—osteoporosis	0.00161	0.00404	CcSEcCtD
Oxazepam—Dermatitis—Etidronic acid—osteoporosis	0.0016	0.00404	CcSEcCtD
Oxazepam—Vertigo—Conjugated Estrogens—osteoporosis	0.0016	0.00403	CcSEcCtD
Oxazepam—Syncope—Conjugated Estrogens—osteoporosis	0.0016	0.00403	CcSEcCtD
Oxazepam—Hypersensitivity—Alendronate—osteoporosis	0.0016	0.00402	CcSEcCtD
Oxazepam—Headache—Etidronic acid—osteoporosis	0.0016	0.00402	CcSEcCtD
Oxazepam—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00157	0.00395	CcSEcCtD
Oxazepam—Paraesthesia—Risedronate—osteoporosis	0.00156	0.00394	CcSEcCtD
Oxazepam—Hypersensitivity—Ibandronate—osteoporosis	0.00156	0.00392	CcSEcCtD
Oxazepam—Hypotension—Pamidronate—osteoporosis	0.00155	0.00389	CcSEcCtD
Oxazepam—Hypersensitivity—Calcitriol—osteoporosis	0.00152	0.00384	CcSEcCtD
Oxazepam—Nausea—Etidronic acid—osteoporosis	0.00151	0.00381	CcSEcCtD
Oxazepam—Oedema—Zoledronate—osteoporosis	0.00151	0.00381	CcSEcCtD
Oxazepam—Shock—Zoledronate—osteoporosis	0.00149	0.00374	CcSEcCtD
Oxazepam—Paraesthesia—Pamidronate—osteoporosis	0.00149	0.00374	CcSEcCtD
Oxazepam—Somnolence—Pamidronate—osteoporosis	0.00147	0.0037	CcSEcCtD
Oxazepam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00146	0.00368	CcSEcCtD
Oxazepam—Dizziness—Estropipate—osteoporosis	0.00146	0.00367	CcSEcCtD
Oxazepam—Oedema—Conjugated Estrogens—osteoporosis	0.00146	0.00366	CcSEcCtD
Oxazepam—Dizziness—Alendronate—osteoporosis	0.00144	0.00361	CcSEcCtD
Oxazepam—Shock—Conjugated Estrogens—osteoporosis	0.00143	0.00361	CcSEcCtD
Oxazepam—Gastrointestinal pain—Risedronate—osteoporosis	0.00142	0.00358	CcSEcCtD
Oxazepam—Hypotension—Zoledronate—osteoporosis	0.00141	0.00356	CcSEcCtD
Oxazepam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00141	0.00355	CcSEcCtD
Oxazepam—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00141	0.00355	CcSEcCtD
Oxazepam—Dizziness—Raloxifene—osteoporosis	0.00141	0.00355	CcSEcCtD
Oxazepam—Dizziness—Ibandronate—osteoporosis	0.0014	0.00352	CcSEcCtD
Oxazepam—Rash—Estropipate—osteoporosis	0.00139	0.0035	CcSEcCtD
Oxazepam—Dermatitis—Estropipate—osteoporosis	0.00139	0.00349	CcSEcCtD
Oxazepam—Headache—Estropipate—osteoporosis	0.00138	0.00347	CcSEcCtD
Oxazepam—Abdominal pain—Risedronate—osteoporosis	0.00138	0.00347	CcSEcCtD
Oxazepam—Body temperature increased—Risedronate—osteoporosis	0.00138	0.00347	CcSEcCtD
Oxazepam—Rash—Alendronate—osteoporosis	0.00137	0.00344	CcSEcCtD
Oxazepam—Dermatitis—Alendronate—osteoporosis	0.00137	0.00344	CcSEcCtD
Oxazepam—Hypotension—Conjugated Estrogens—osteoporosis	0.00136	0.00342	CcSEcCtD
Oxazepam—Headache—Alendronate—osteoporosis	0.00136	0.00342	CcSEcCtD
Oxazepam—Paraesthesia—Zoledronate—osteoporosis	0.00136	0.00342	CcSEcCtD
Oxazepam—Gastrointestinal pain—Pamidronate—osteoporosis	0.00135	0.00341	CcSEcCtD
Oxazepam—Rash—Raloxifene—osteoporosis	0.00135	0.00339	CcSEcCtD
Oxazepam—Dermatitis—Raloxifene—osteoporosis	0.00134	0.00338	CcSEcCtD
Oxazepam—Somnolence—Zoledronate—osteoporosis	0.00134	0.00338	CcSEcCtD
Oxazepam—Tremor—Estradiol—osteoporosis	0.00134	0.00337	CcSEcCtD
Oxazepam—Headache—Raloxifene—osteoporosis	0.00134	0.00337	CcSEcCtD
Oxazepam—Rash—Ibandronate—osteoporosis	0.00133	0.00335	CcSEcCtD
Oxazepam—Dermatitis—Ibandronate—osteoporosis	0.00133	0.00335	CcSEcCtD
Oxazepam—Headache—Ibandronate—osteoporosis	0.00132	0.00333	CcSEcCtD
Oxazepam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00132	0.00331	CcSEcCtD
Oxazepam—Agitation—Estradiol—osteoporosis	0.00131	0.0033	CcSEcCtD
Oxazepam—Nausea—Estropipate—osteoporosis	0.00131	0.00329	CcSEcCtD
Oxazepam—Abdominal pain—Pamidronate—osteoporosis	0.00131	0.00329	CcSEcCtD
Oxazepam—Body temperature increased—Pamidronate—osteoporosis	0.00131	0.00329	CcSEcCtD
Oxazepam—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00131	0.00329	CcSEcCtD
Oxazepam—Rash—Calcitriol—osteoporosis	0.0013	0.00328	CcSEcCtD
Oxazepam—Dermatitis—Calcitriol—osteoporosis	0.0013	0.00328	CcSEcCtD
Oxazepam—Headache—Calcitriol—osteoporosis	0.0013	0.00326	CcSEcCtD
Oxazepam—Somnolence—Conjugated Estrogens—osteoporosis	0.00129	0.00326	CcSEcCtD
Oxazepam—Nausea—Alendronate—osteoporosis	0.00129	0.00324	CcSEcCtD
Oxazepam—Hypersensitivity—Risedronate—osteoporosis	0.00128	0.00323	CcSEcCtD
Oxazepam—Vertigo—Estradiol—osteoporosis	0.00128	0.00323	CcSEcCtD
Oxazepam—Syncope—Estradiol—osteoporosis	0.00128	0.00322	CcSEcCtD
Oxazepam—Nausea—Raloxifene—osteoporosis	0.00127	0.00319	CcSEcCtD
Oxazepam—Nausea—Ibandronate—osteoporosis	0.00126	0.00316	CcSEcCtD
Oxazepam—Loss of consciousness—Estradiol—osteoporosis	0.00126	0.00316	CcSEcCtD
Oxazepam—Gastrointestinal pain—Zoledronate—osteoporosis	0.00124	0.00311	CcSEcCtD
Oxazepam—Nausea—Calcitriol—osteoporosis	0.00123	0.00309	CcSEcCtD
Oxazepam—Hypersensitivity—Pamidronate—osteoporosis	0.00122	0.00307	CcSEcCtD
Oxazepam—Abdominal pain—Zoledronate—osteoporosis	0.0012	0.00301	CcSEcCtD
Oxazepam—Body temperature increased—Zoledronate—osteoporosis	0.0012	0.00301	CcSEcCtD
Oxazepam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00119	0.003	CcSEcCtD
Oxazepam—Dizziness—Ethinyl Estradiol—osteoporosis	0.00118	0.00297	CcSEcCtD
Oxazepam—Oedema—Estradiol—osteoporosis	0.00117	0.00293	CcSEcCtD
Oxazepam—Dizziness—Risedronate—osteoporosis	0.00115	0.0029	CcSEcCtD
Oxazepam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00115	0.0029	CcSEcCtD
Oxazepam—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00115	0.0029	CcSEcCtD
Oxazepam—Shock—Estradiol—osteoporosis	0.00115	0.00289	CcSEcCtD
Oxazepam—Rash—Ethinyl Estradiol—osteoporosis	0.00113	0.00283	CcSEcCtD
Oxazepam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00113	0.00283	CcSEcCtD
Oxazepam—Headache—Ethinyl Estradiol—osteoporosis	0.00112	0.00282	CcSEcCtD
Oxazepam—Hypersensitivity—Zoledronate—osteoporosis	0.00111	0.0028	CcSEcCtD
Oxazepam—Rash—Risedronate—osteoporosis	0.0011	0.00276	CcSEcCtD
Oxazepam—Dermatitis—Risedronate—osteoporosis	0.0011	0.00276	CcSEcCtD
Oxazepam—Dizziness—Pamidronate—osteoporosis	0.00109	0.00276	CcSEcCtD
Oxazepam—Headache—Risedronate—osteoporosis	0.00109	0.00275	CcSEcCtD
Oxazepam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00107	0.0027	CcSEcCtD
Oxazepam—Nausea—Ethinyl Estradiol—osteoporosis	0.00106	0.00267	CcSEcCtD
Oxazepam—Paraesthesia—Estradiol—osteoporosis	0.00105	0.00263	CcSEcCtD
Oxazepam—Rash—Pamidronate—osteoporosis	0.00104	0.00263	CcSEcCtD
Oxazepam—Dermatitis—Pamidronate—osteoporosis	0.00104	0.00262	CcSEcCtD
Oxazepam—Headache—Pamidronate—osteoporosis	0.00104	0.00261	CcSEcCtD
Oxazepam—Somnolence—Estradiol—osteoporosis	0.00104	0.00261	CcSEcCtD
Oxazepam—Nausea—Risedronate—osteoporosis	0.00103	0.0026	CcSEcCtD
Oxazepam—Dizziness—Zoledronate—osteoporosis	0.001	0.00252	CcSEcCtD
Oxazepam—Nausea—Pamidronate—osteoporosis	0.000983	0.00248	CcSEcCtD
Oxazepam—Dizziness—Conjugated Estrogens—osteoporosis	0.000963	0.00242	CcSEcCtD
Oxazepam—Rash—Zoledronate—osteoporosis	0.000954	0.0024	CcSEcCtD
Oxazepam—Gastrointestinal pain—Estradiol—osteoporosis	0.000953	0.0024	CcSEcCtD
Oxazepam—Dermatitis—Zoledronate—osteoporosis	0.000953	0.0024	CcSEcCtD
Oxazepam—Headache—Zoledronate—osteoporosis	0.000947	0.00238	CcSEcCtD
Oxazepam—Body temperature increased—Estradiol—osteoporosis	0.000921	0.00232	CcSEcCtD
Oxazepam—Abdominal pain—Estradiol—osteoporosis	0.000921	0.00232	CcSEcCtD
Oxazepam—Rash—Conjugated Estrogens—osteoporosis	0.000918	0.00231	CcSEcCtD
Oxazepam—Dermatitis—Conjugated Estrogens—osteoporosis	0.000917	0.00231	CcSEcCtD
Oxazepam—Headache—Conjugated Estrogens—osteoporosis	0.000912	0.0023	CcSEcCtD
Oxazepam—Nausea—Zoledronate—osteoporosis	0.000898	0.00226	CcSEcCtD
Oxazepam—Nausea—Conjugated Estrogens—osteoporosis	0.000865	0.00218	CcSEcCtD
Oxazepam—Hypersensitivity—Estradiol—osteoporosis	0.000859	0.00216	CcSEcCtD
Oxazepam—Dizziness—Estradiol—osteoporosis	0.000771	0.00194	CcSEcCtD
Oxazepam—Rash—Estradiol—osteoporosis	0.000735	0.00185	CcSEcCtD
Oxazepam—Dermatitis—Estradiol—osteoporosis	0.000734	0.00185	CcSEcCtD
Oxazepam—Headache—Estradiol—osteoporosis	0.00073	0.00184	CcSEcCtD
Oxazepam—Nausea—Estradiol—osteoporosis	0.000692	0.00174	CcSEcCtD
Oxazepam—CYP3A43—Metabolism—PNP—osteoporosis	0.000171	0.00265	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ATIC—osteoporosis	0.000171	0.00265	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000168	0.00261	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	0.000168	0.0026	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000168	0.0026	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—CYP19A1—osteoporosis	0.000166	0.00258	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000166	0.00257	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000165	0.00257	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP19A1—osteoporosis	0.000164	0.00255	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000164	0.00254	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—SPP1—osteoporosis	0.000162	0.00251	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000161	0.0025	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—ADCY5—osteoporosis	0.00016	0.00248	CbGpPWpGaD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000158	0.00246	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000156	0.00242	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—IDH2—osteoporosis	0.000156	0.00242	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—AGER—osteoporosis	0.000155	0.00241	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000155	0.0024	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000153	0.00237	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—ADCY5—osteoporosis	0.000152	0.00236	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—ADCY5—osteoporosis	0.000152	0.00236	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000152	0.00236	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000151	0.00235	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000151	0.00234	CbGpPWpGaD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00015	0.00233	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000147	0.00228	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—osteoporosis	0.000147	0.00227	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP27A1—osteoporosis	0.000146	0.00227	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—IRS2—osteoporosis	0.000146	0.00227	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—OXCT1—osteoporosis	0.000145	0.00225	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CA2—osteoporosis	0.000145	0.00225	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000144	0.00224	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ACP5—osteoporosis	0.000142	0.00221	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000142	0.0022	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MGLL—osteoporosis	0.000141	0.0022	CbGpPWpGaD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000141	0.00219	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000141	0.00219	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	0.00014	0.00217	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000138	0.00215	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	0.000138	0.00214	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000138	0.00214	CbGpPWpGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000135	0.0021	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000134	0.00208	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—TPI1—osteoporosis	0.000132	0.00205	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000131	0.00204	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000129	0.00201	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000128	0.00199	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—IRS1—osteoporosis	0.000128	0.00198	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000126	0.00196	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—ADCY5—osteoporosis	0.000125	0.00195	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—P4HB—osteoporosis	0.000124	0.00193	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—ADCY5—osteoporosis	0.000124	0.00192	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—POMC—osteoporosis	0.000123	0.00191	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GAPDH—osteoporosis	0.000122	0.0019	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000122	0.00189	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000121	0.00188	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—IDH2—osteoporosis	0.00012	0.00187	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—RAP1A—osteoporosis	0.000119	0.00185	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—ADCY5—osteoporosis	0.000117	0.00181	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—FDPS—osteoporosis	0.000116	0.0018	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PKM—osteoporosis	0.000116	0.0018	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—ADCY5—osteoporosis	0.000115	0.00179	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000114	0.00178	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP27A1—osteoporosis	0.000113	0.00175	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00011	0.00171	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ACP5—osteoporosis	0.00011	0.00171	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PGLS—osteoporosis	0.00011	0.00171	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GPD2—osteoporosis	0.00011	0.00171	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000109	0.00169	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000108	0.00167	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—ADCY5—osteoporosis	0.000106	0.00164	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000103	0.0016	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—ADCY5—osteoporosis	0.000103	0.00159	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TPI1—osteoporosis	0.000102	0.00159	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	0.000101	0.00157	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—ADCY5—osteoporosis	0.000101	0.00156	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ATIC—osteoporosis	0.000101	0.00156	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PNP—osteoporosis	0.000101	0.00156	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—POMC—osteoporosis	0.0001	0.00155	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	9.97e-05	0.00155	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—ADCY5—osteoporosis	9.9e-05	0.00154	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—ADCY5—osteoporosis	9.84e-05	0.00153	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—ADCY5—osteoporosis	9.66e-05	0.0015	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL6R—osteoporosis	9.64e-05	0.0015	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—P4HB—osteoporosis	9.61e-05	0.00149	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ENO1—osteoporosis	9.61e-05	0.00149	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PSMA2—osteoporosis	9.47e-05	0.00147	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PSMA5—osteoporosis	9.47e-05	0.00147	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GAPDH—osteoporosis	9.44e-05	0.00146	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—FDPS—osteoporosis	9.43e-05	0.00146	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PKM—osteoporosis	9.43e-05	0.00146	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—RAP1A—osteoporosis	9.19e-05	0.00143	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.95e-05	0.00139	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GPD2—osteoporosis	8.94e-05	0.00139	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PGLS—osteoporosis	8.94e-05	0.00139	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.85e-05	0.00137	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.83e-05	0.00137	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.59e-05	0.00133	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CA2—osteoporosis	8.55e-05	0.00133	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—OXCT1—osteoporosis	8.55e-05	0.00133	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—ADCY5—osteoporosis	8.44e-05	0.00131	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—POMC—osteoporosis	8.41e-05	0.0013	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MGLL—osteoporosis	8.34e-05	0.00129	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.19e-05	0.00127	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.19e-05	0.00127	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PNP—osteoporosis	8.18e-05	0.00127	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ATIC—osteoporosis	8.18e-05	0.00127	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—TGFB1—osteoporosis	8.09e-05	0.00126	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PKM—osteoporosis	7.93e-05	0.00123	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—FDPS—osteoporosis	7.93e-05	0.00123	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP19A1—osteoporosis	7.69e-05	0.00119	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PGLS—osteoporosis	7.52e-05	0.00117	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GPD2—osteoporosis	7.52e-05	0.00117	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ENO1—osteoporosis	7.43e-05	0.00115	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoporosis	7.34e-05	0.00114	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PSMA5—osteoporosis	7.32e-05	0.00114	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PSMA2—osteoporosis	7.32e-05	0.00114	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—IDH2—osteoporosis	7.09e-05	0.0011	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CA2—osteoporosis	6.95e-05	0.00108	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—OXCT1—osteoporosis	6.95e-05	0.00108	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ATIC—osteoporosis	6.88e-05	0.00107	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PNP—osteoporosis	6.88e-05	0.00107	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MGLL—osteoporosis	6.77e-05	0.00105	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.75e-05	0.00105	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP27A1—osteoporosis	6.66e-05	0.00103	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.64e-05	0.00103	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	6.57e-05	0.00102	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.56e-05	0.00102	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ACP5—osteoporosis	6.48e-05	0.00101	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.39e-05	0.000991	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.29e-05	0.000976	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ADCY5—osteoporosis	6.28e-05	0.000975	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—GPX1—osteoporosis	6.26e-05	0.000971	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.21e-05	0.000963	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—POMC—osteoporosis	6.08e-05	0.000943	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TPI1—osteoporosis	6.03e-05	0.000935	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP19A1—osteoporosis	5.94e-05	0.000922	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—OXCT1—osteoporosis	5.85e-05	0.000907	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CA2—osteoporosis	5.85e-05	0.000907	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—MTHFR—osteoporosis	5.78e-05	0.000896	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—IDH2—osteoporosis	5.76e-05	0.000894	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PKM—osteoporosis	5.73e-05	0.00089	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—FDPS—osteoporosis	5.73e-05	0.00089	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MGLL—osteoporosis	5.7e-05	0.000884	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.68e-05	0.000881	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—P4HB—osteoporosis	5.67e-05	0.000879	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GAPDH—osteoporosis	5.56e-05	0.000863	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.52e-05	0.000856	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GPD2—osteoporosis	5.43e-05	0.000843	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PGLS—osteoporosis	5.43e-05	0.000843	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—RAP1A—osteoporosis	5.42e-05	0.000841	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.42e-05	0.000841	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP27A1—osteoporosis	5.42e-05	0.00084	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—osteoporosis	5.32e-05	0.000826	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.32e-05	0.000826	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.32e-05	0.000826	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.29e-05	0.000821	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ACP5—osteoporosis	5.27e-05	0.000818	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.2e-05	0.000807	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.19e-05	0.000806	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PNP—osteoporosis	4.97e-05	0.000771	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ATIC—osteoporosis	4.97e-05	0.000771	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TPI1—osteoporosis	4.9e-05	0.00076	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ADCY5—osteoporosis	4.85e-05	0.000753	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—IDH2—osteoporosis	4.84e-05	0.000752	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—GPX1—osteoporosis	4.84e-05	0.000751	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.7e-05	0.00073	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.64e-05	0.00072	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—POMC—osteoporosis	4.62e-05	0.000717	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—P4HB—osteoporosis	4.6e-05	0.000715	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP27A1—osteoporosis	4.55e-05	0.000707	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.54e-05	0.000704	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GAPDH—osteoporosis	4.52e-05	0.000701	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MTHFR—osteoporosis	4.46e-05	0.000693	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ACP5—osteoporosis	4.43e-05	0.000688	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—RAP1A—osteoporosis	4.4e-05	0.000683	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ENO1—osteoporosis	4.38e-05	0.00068	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PSMA2—osteoporosis	4.32e-05	0.00067	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PSMA5—osteoporosis	4.32e-05	0.00067	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL6—osteoporosis	4.3e-05	0.000667	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CA2—osteoporosis	4.23e-05	0.000656	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—OXCT1—osteoporosis	4.23e-05	0.000656	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TPI1—osteoporosis	4.12e-05	0.000639	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MGLL—osteoporosis	4.12e-05	0.000639	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—P4HB—osteoporosis	3.87e-05	0.000601	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.84e-05	0.000596	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GAPDH—osteoporosis	3.8e-05	0.00059	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—RAP1A—osteoporosis	3.7e-05	0.000575	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—POMC—osteoporosis	3.57e-05	0.000554	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ENO1—osteoporosis	3.56e-05	0.000552	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PSMA5—osteoporosis	3.51e-05	0.000544	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PSMA2—osteoporosis	3.51e-05	0.000544	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—IDH2—osteoporosis	3.5e-05	0.000543	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP19A1—osteoporosis	3.5e-05	0.000543	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP27A1—osteoporosis	3.29e-05	0.000511	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ACP5—osteoporosis	3.2e-05	0.000497	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ENO1—osteoporosis	2.99e-05	0.000464	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TPI1—osteoporosis	2.98e-05	0.000462	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PSMA2—osteoporosis	2.95e-05	0.000458	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PSMA5—osteoporosis	2.95e-05	0.000458	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ADCY5—osteoporosis	2.86e-05	0.000444	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—GPX1—osteoporosis	2.85e-05	0.000442	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP19A1—osteoporosis	2.84e-05	0.000441	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—POMC—osteoporosis	2.83e-05	0.000439	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—P4HB—osteoporosis	2.8e-05	0.000434	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GAPDH—osteoporosis	2.75e-05	0.000426	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—RAP1A—osteoporosis	2.68e-05	0.000415	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PKM—osteoporosis	2.66e-05	0.000414	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—FDPS—osteoporosis	2.66e-05	0.000414	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MTHFR—osteoporosis	2.63e-05	0.000408	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GPD2—osteoporosis	2.53e-05	0.000392	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PGLS—osteoporosis	2.53e-05	0.000392	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP19A1—osteoporosis	2.39e-05	0.000371	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ADCY5—osteoporosis	2.32e-05	0.000361	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—GPX1—osteoporosis	2.32e-05	0.000359	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PNP—osteoporosis	2.31e-05	0.000359	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ATIC—osteoporosis	2.31e-05	0.000359	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ENO1—osteoporosis	2.16e-05	0.000336	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MTHFR—osteoporosis	2.14e-05	0.000332	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PSMA5—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PSMA2—osteoporosis	2.13e-05	0.000331	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—POMC—osteoporosis	2.1e-05	0.000327	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CA2—osteoporosis	1.96e-05	0.000305	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—OXCT1—osteoporosis	1.96e-05	0.000305	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ADCY5—osteoporosis	1.95e-05	0.000303	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—GPX1—osteoporosis	1.95e-05	0.000302	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MGLL—osteoporosis	1.91e-05	0.000297	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MTHFR—osteoporosis	1.8e-05	0.000279	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.73e-05	0.000268	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—POMC—osteoporosis	1.71e-05	0.000265	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—IDH2—osteoporosis	1.63e-05	0.000253	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.53e-05	0.000238	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ACP5—osteoporosis	1.49e-05	0.000231	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—POMC—osteoporosis	1.44e-05	0.000223	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000219	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—GPX1—osteoporosis	1.41e-05	0.000219	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TPI1—osteoporosis	1.38e-05	0.000215	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—P4HB—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MTHFR—osteoporosis	1.3e-05	0.000202	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000198	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000193	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—POMC—osteoporosis	1.04e-05	0.000161	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ENO1—osteoporosis	1.01e-05	0.000156	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PSMA2—osteoporosis	9.91e-06	0.000154	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PSMA5—osteoporosis	9.91e-06	0.000154	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.04e-06	0.000125	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ADCY5—osteoporosis	6.57e-06	0.000102	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—GPX1—osteoporosis	6.55e-06	0.000102	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MTHFR—osteoporosis	6.04e-06	9.38e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—POMC—osteoporosis	4.83e-06	7.5e-05	CbGpPWpGaD
